BioWorld Science

Feb. 17, 2020

View Archived Issues

scRNA-seq of Trypanosoma brucei from tsetse reveals candidates for a transmission-blocking vaccine

Read More

Anti-IL-1b platelet conjugate prevents sterile inflammation and adverse cardiac remodeling after AMI

Read More

Positive data for RECCE-327 in models of kidney and UTI infection

Read More

Sihuan Pharmaceutical initiates phase III study of anaprazole sodium in duodenal ulcer

Read More

GeneTx receives approval to initiate phase I/II study GTX-102

Read More

Phase I data presented for fosciclopirox in advanced solid tumors

Read More

Bayer presents data from phase II/III FORT-1 study of rogaratinib

Read More

Preliminary data presented from POLARIS-03 study of toripalimab in UC

Read More

Hinova Pharmaceuticals discovers new BRD4 inhibitors

Read More

High affinity nerve growth factor receptor inhibitors presented by JC Pharma

Read More

New IDO-1 inhibitors identified at Bristol-Myers Squibb

Read More

Domain Therapeutics patents mGluR4 positive allosteric modulators

Read More

Dual mu-opioid/voltage-gated calcium channels alpha2/delta-1 subunit ligands synthesized at Esteve

Read More

Ebola survivor's antibodies reveal therapeutic targets

Read More

Origin story helps ovarian cancer prognosis

Read More

Kinase, caspase play unexpected roles in NASH

Read More

MAO-A inhibitor phenelzine shows promise for treating recurrent prostate cancer

Read More

Phase I preliminary data presented for ACTUS-101 in late-onset Pompe disease

Read More

The Year's New Drugs & Biologics reviews 2019's new drugs and candidates for 2020 approval

Read More

FDA approves Twirla contraceptive patch

Read More

Beovu approved in E.U. for wet AMD

Read More